Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.
The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists.
Crohn’s disease and ulcerative colitis (UC) are both types of inflammatory bowel disease (IBD) that share similar symptoms but differ in their affected areas, disease progression, and treatment ...
Among the overarching trends is earlier and earlier treatment intensification to forestall development of metastases and castration-resistant prostate cancer (CRPC). Triplet therapy with docetaxel ...